Hong Kong Life Sciences and Technologies Group Ltd operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hong Kong Life Sciences and Technologies Group Ltd with three other
drug stores in Asia:
Extrawell Pharmaceutical Holdings Limited
sales of 142.20 million Hong Kong Dollars [US$18.33 million]
of which 70%
Ibl Healthcare Limited
(1.16 billion Pakistan Rupees [US$11.03 million]
Immuno-Biological Laboratories Company Limited
based in Japan
(717.66 million Japanese Yen [US$6.26 million]
of which 73%
was Diagnosis & Reagent).
Hong Kong Life Sciences and Technologies Group Ltd reported sales of HK$123.37 million (US$15.91 million)
March of 2016.
decrease of 61.9%
versus 2015, when the company's sales were HK$324.16 million.
Contributing to the drop in overall sales was the 67.1% decline
in Trading Business, from HK$289.52 million to HK$95.15 million.
There were also decreases in sales in
Anti-Aging and Stem Cell Technology Busine (down 51.2% to HK$7.92 million)
Hotel Operations (down 64.9% to HK$1.43 million)
However, these declines were partially offset by the increase in sales of
Money Lending Business (up 39.5% to HK$19.97 million)